| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate phosphatase activity | 3.10e-07 | 27 | 210 | 6 | GO:0034593 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate phosphatase activity | 6.06e-07 | 30 | 210 | 6 | GO:0052866 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate phosphatase activity | 5.51e-06 | 12 | 210 | 4 | GO:0106019 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 2.38e-05 | 55 | 210 | 6 | GO:0042974 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.24e-05 | 18 | 210 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.56e-05 | 118 | 210 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 9.43e-05 | 70 | 210 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | TFIIIC-class transcription factor complex binding | 1.10e-04 | 2 | 210 | 2 | GO:0001156 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity | 1.30e-04 | 10 | 210 | 3 | GO:0004439 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate 4-phosphatase activity | 1.30e-04 | 10 | 210 | 3 | GO:0034596 | |
| GeneOntologyMolecularFunction | transcription factor binding | BDP1 STK36 NCOA6 LPIN1 SATB1 YAP1 HES6 NOTCH2 DNMT1 FOXO3 DR1 PRAMEF15 NSD1 PRAMEF4 MED1 JMJD1C NLRP3 MTOR PRAMEF27 TP53BP2 | 1.42e-04 | 753 | 210 | 20 | GO:0008134 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.00e-04 | 28 | 210 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate 5-phosphatase activity | 3.03e-04 | 13 | 210 | 3 | GO:0034595 | |
| GeneOntologyMolecularFunction | inositol trisphosphate phosphatase activity | 3.83e-04 | 14 | 210 | 3 | GO:0046030 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 4.31e-04 | 34 | 210 | 4 | GO:0046966 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 5.98e-04 | 37 | 210 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | RNA polymerase III general transcription initiation factor binding | 6.51e-04 | 4 | 210 | 2 | GO:0001025 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine N-sulfotransferase activity | 6.51e-04 | 4 | 210 | 2 | GO:0015016 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine deacetylase activity | 6.51e-04 | 4 | 210 | 2 | GO:0050119 | |
| GeneOntologyMolecularFunction | GTPase activator activity | ACAP1 RIN3 MYO9A ARHGEF11 ARHGAP31 TBC1D1 RASAL2 ASAP3 OCRL ARHGAP6 | 7.72e-04 | 279 | 210 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | deacetylase activity | 8.08e-04 | 40 | 210 | 4 | GO:0019213 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA3 MYO7B MYO9A ATP8A2 KIF19 ABCD2 DNAH6 DNAH9 KIF26B SMCHD1 MSH5 NLRP3 DNAH17 ATP5F1B DNAH11 HELLS | 8.13e-04 | 614 | 210 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | nuclear receptor binding | 8.37e-04 | 187 | 210 | 8 | GO:0016922 | |
| GeneOntologyMolecularFunction | phosphatase activity | INPP4A INPP5D LPIN1 MTMR3 PIP4P2 PPP4R1 PTPMT1 PPM1E OCRL CDC25A | 9.57e-04 | 287 | 210 | 10 | GO:0016791 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ACAP1 RIN3 TRIO MYO9A ARHGEF11 SH3BP4 ARHGAP31 TBC1D1 DNMBP RASAL2 ASAP3 OCRL MON1A ARHGAP6 | 9.93e-04 | 507 | 210 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ACAP1 RIN3 TRIO MYO9A ARHGEF11 SH3BP4 ARHGAP31 TBC1D1 DNMBP RASAL2 ASAP3 OCRL MON1A ARHGAP6 | 9.93e-04 | 507 | 210 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | inositol phosphate phosphatase activity | 1.15e-03 | 20 | 210 | 3 | GO:0052745 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | NCOA6 LPIN1 SATB1 YAP1 HES6 NOTCH2 DNMT1 PRAMEF15 NSD1 PRAMEF4 MED1 JMJD1C NLRP3 PRAMEF27 TP53BP2 | 1.32e-03 | 582 | 210 | 15 | GO:0140297 |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.33e-03 | 21 | 210 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | NCOA6 LPIN1 HES6 NOTCH2 DNMT1 PRAMEF15 NSD1 PRAMEF4 MED1 JMJD1C PRAMEF27 TP53BP2 | 1.60e-03 | 417 | 210 | 12 | GO:0061629 |
| GeneOntologyMolecularFunction | molecular adaptor activity | MYT1L NCOA6 PRAMEF9 GATAD2A NAPG TSG101 TRRAP LPIN1 MRTFB YAP1 SYNE2 PLCB3 MIER2 STX8 RNF169 PRAMEF15 NSD1 PRAMEF4 MED1 JMJD1C NLRP3 RLIM AKAP1 PCBP2 PRAMEF27 PCNT | 2.19e-03 | 1356 | 210 | 26 | GO:0060090 |
| GeneOntologyMolecularFunction | inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity | 2.23e-03 | 7 | 210 | 2 | GO:0052659 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity | 2.23e-03 | 7 | 210 | 2 | GO:0034485 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 2.33e-03 | 53 | 210 | 4 | GO:0030331 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | INPP4A INPP5D LPIN1 MTMR3 PLCB3 PIP4P2 PPP4R1 PTPMT1 PPM1E OCRL CDC25A | 2.68e-03 | 386 | 210 | 11 | GO:0042578 |
| GeneOntologyMolecularFunction | inositol-polyphosphate 5-phosphatase activity | 2.96e-03 | 8 | 210 | 2 | GO:0004445 | |
| GeneOntologyMolecularFunction | inositol bisphosphate phosphatase activity | 2.96e-03 | 8 | 210 | 2 | GO:0016312 | |
| GeneOntologyMolecularFunction | inositol-1,4,5-trisphosphate 5-phosphatase activity | 2.96e-03 | 8 | 210 | 2 | GO:0052658 | |
| Domain | PRAME_family | 4.99e-05 | 19 | 207 | 4 | IPR026271 | |
| Domain | PH_dom-like | ACAP1 TRIO MYO7B ARHGEF11 TBC1D1 MTMR3 PLCB3 PLEKHA7 RASAL2 ASAP3 VPS36 ELMO3 PLEKHA3 DAPP1 | 2.99e-04 | 426 | 207 | 14 | IPR011993 |
| Domain | AH/BAR-dom | 3.20e-04 | 30 | 207 | 4 | IPR027267 | |
| Domain | - | 3.20e-04 | 30 | 207 | 4 | 1.20.1270.60 | |
| Domain | Teashirt_fam | 3.64e-04 | 3 | 207 | 2 | IPR027008 | |
| Domain | - | ACAP1 TRIO MYO7B ARHGEF11 TBC1D1 MTMR3 PLCB3 PLEKHA7 RASAL2 ASAP3 ELMO3 PLEKHA3 DAPP1 | 4.39e-04 | 391 | 207 | 13 | 2.30.29.30 |
| Domain | Dynein_heavy_chain_D4_dom | 4.46e-04 | 14 | 207 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.46e-04 | 14 | 207 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.46e-04 | 14 | 207 | 3 | IPR013602 | |
| Domain | DHC_N2 | 4.46e-04 | 14 | 207 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.46e-04 | 14 | 207 | 3 | IPR011704 | |
| Domain | MT | 4.46e-04 | 14 | 207 | 3 | PF12777 | |
| Domain | AAA_8 | 4.46e-04 | 14 | 207 | 3 | PF12780 | |
| Domain | AAA_5 | 4.46e-04 | 14 | 207 | 3 | PF07728 | |
| Domain | - | ACAP1 ANKS4B TRANK1 ANKRD34B ANKIB1 NOTCH2 ANKRD35 ASAP3 ANKS3 TP53BP2 | 4.63e-04 | 248 | 207 | 10 | 1.25.40.20 |
| Domain | ANK | ACAP1 ANKS4B TRANK1 ANKRD34B ANKIB1 NOTCH2 ANKRD35 ASAP3 ANKS3 TP53BP2 | 5.08e-04 | 251 | 207 | 10 | SM00248 |
| Domain | ANK_REPEAT | ACAP1 ANKS4B TRANK1 ANKRD34B ANKIB1 NOTCH2 ANKRD35 ASAP3 ANKS3 TP53BP2 | 5.41e-04 | 253 | 207 | 10 | PS50088 |
| Domain | DHC_fam | 5.53e-04 | 15 | 207 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 5.53e-04 | 15 | 207 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 5.53e-04 | 15 | 207 | 3 | IPR004273 | |
| Domain | Ankyrin_rpt-contain_dom | ACAP1 ANKS4B TRANK1 ANKRD34B ANKIB1 NOTCH2 ANKRD35 ASAP3 ANKS3 TP53BP2 | 5.58e-04 | 254 | 207 | 10 | IPR020683 |
| Domain | ANK_REP_REGION | ACAP1 ANKS4B TRANK1 ANKRD34B ANKIB1 NOTCH2 ANKRD35 ASAP3 ANKS3 TP53BP2 | 5.58e-04 | 254 | 207 | 10 | PS50297 |
| Domain | Ankyrin_rpt | ACAP1 ANKS4B TRANK1 ANKRD34B ANKIB1 NOTCH2 ANKRD35 ASAP3 ANKS3 TP53BP2 | 7.08e-04 | 262 | 207 | 10 | IPR002110 |
| Domain | FAM86 | 7.23e-04 | 4 | 207 | 2 | IPR029426 | |
| Domain | Heparan_SO4_deacetylase | 7.23e-04 | 4 | 207 | 2 | IPR021930 | |
| Domain | FAM86 | 7.23e-04 | 4 | 207 | 2 | PF14904 | |
| Domain | HSNSD | 7.23e-04 | 4 | 207 | 2 | PF12062 | |
| Domain | Ank | ACAP1 ANKS4B ANKRD34B ANKIB1 NOTCH2 ANKRD35 ASAP3 ANKS3 TP53BP2 | 1.03e-03 | 228 | 207 | 9 | PF00023 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NCOA6 NCKAP1 MAP1B TRIO MYO9A KIAA0232 LUZP1 SPICE1 KIAA0753 SH3BP4 BAIAP2L1 YAP1 TBC1D1 SYNE2 MAD1L1 DNMBP PLEKHA7 GOLGB1 NOTCH2 RASAL2 DNMT1 FOXO3 KIF26B PPFIBP1 LMO7 MTOR PLEKHA3 AKAP1 TP53BP2 | 1.28e-13 | 861 | 214 | 29 | 36931259 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | STK36 NCOA6 INPP5D TSG101 SH3BP4 MRTFB BAIAP2L1 ARHGAP31 YAP1 PLEKHA7 TSHZ3 ASAP3 ARHGAP6 MAP4K5 TSHZ1 TP53BP2 PCNT | 1.77e-09 | 430 | 214 | 17 | 35044719 |
| Pubmed | NCOA6 MAP1B TRRAP LUZP1 MRTFB YAP1 DNMT1 SMCHD1 NSD1 GEMIN5 HEATR1 MED1 JMJD1C LMO7 PCBP1 PCBP2 TP53BP2 | 6.36e-08 | 549 | 214 | 17 | 38280479 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | STK36 NCOA6 RIN3 TRIO ARHGEF11 TRRAP ACOX3 SH3BP4 GLI1 MCM3AP MAD1L1 MTMR3 ULK4 HES6 DNMBP NOTCH2 IGSF3 FOXO3 NSD1 GEMIN5 CELSR2 MTOR ULK2 PCNT | 1.01e-07 | 1105 | 214 | 24 | 35748872 |
| Pubmed | MYT1L NCOA6 KIAA0232 SCRN1 MRTFB TBC1D1 SYNE2 SLC23A2 PPFIBP1 LMO7 PCNT | 1.71e-07 | 225 | 214 | 11 | 12168954 | |
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | SH3BP4 YAP1 DNMT1 PPFIBP1 CPS1 LMO7 MTOR CDC25A TP53BP2 ATP5F1B | 3.20e-07 | 190 | 214 | 10 | 15161933 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | NCKAP1 TRIO KIAA0232 ARHGEF11 LUZP1 MRTFB BAIAP2L1 TBC1D1 DNMBP PLEKHA7 FOXO3 PPFIBP1 OCRL FHIP2A CEP164 TMEM131 PCBP1 PCBP2 TP53BP2 PCNT | 3.83e-07 | 853 | 214 | 20 | 28718761 |
| Pubmed | MYT1L GATAD2A ITGA4 SATB1 NOTCH2 FOXO3 SEMA4D TSHZ3 CELSR2 ROBO2 TSHZ1 | 5.10e-07 | 251 | 214 | 11 | 29031500 | |
| Pubmed | NCKAP1 SH3BP4 BAIAP2L1 YAP1 TBC1D1 RASAL2 FOXO3 PPFIBP1 LMO7 TP53BP2 ATP5F1B | 5.96e-07 | 255 | 214 | 11 | 15324660 | |
| Pubmed | NCKAP1 LUZP1 SPICE1 KIAA0753 YAP1 TBC1D1 MTMR3 PLEKHA7 NOTCH2 RASAL2 FOXO3 PPFIBP1 LMO7 TP53BP2 | 8.14e-07 | 446 | 214 | 14 | 24255178 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BDP1 MYO9A MECOM LUZP1 MRTFB BAIAP2L1 YAP1 MCM3AP DNMBP GOLGB1 PPP4R1 KRT14 IKZF3 LMO7 PCBP2 PCNT | 8.71e-07 | 588 | 214 | 16 | 38580884 |
| Pubmed | 9.15e-07 | 4 | 214 | 3 | 21553025 | ||
| Pubmed | NCKAP1 KIAA0232 KIRREL3 TBC1D1 MCM3AP MTMR3 SLC23A2 PPM1E FHIP2A SPHKAP ULK2 PCNT PDZD2 | 1.67e-06 | 407 | 214 | 13 | 12693553 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | GATAD2A NCKAP1 MAP1B MECOM SIX4 TRRAP SATB1 GLI1 MAD1L1 NOTCH2 FOXO3 RBL2 REL HEATR1 CPS1 JMJD1C TSHZ1 CDC25A HELLS | 1.73e-06 | 857 | 214 | 19 | 25609649 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | MECOM SPICE1 KIAA0753 ARHGAP31 MCM3AP NOTCH2 RASAL2 RNF169 JMJD1C | 2.30e-06 | 184 | 214 | 9 | 32908313 |
| Pubmed | SPICE1 KIAA0753 SYNE2 DDHD2 DNMBP PLEKHA7 PPFIBP1 LMO7 PCBP1 HELLS | 3.97e-06 | 251 | 214 | 10 | 29778605 | |
| Pubmed | 4.53e-06 | 6 | 214 | 3 | 29551912 | ||
| Pubmed | Primary cilia maintain corneal epithelial homeostasis by regulation of the Notch signaling pathway. | 5.02e-06 | 19 | 214 | 4 | 27122169 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 MAP1B TRIO MYO9A INPP4A KIAA0232 TRRAP SH3BP4 EXD3 MRTFB TBC1D1 MAD1L1 ANKIB1 GOLGB1 NOTCH2 FOXO3 SEMA4D DDR1 MSH5 JMJD1C ARHGAP6 TSPAN10 ZFP64 PCNT PDZD2 | 5.80e-06 | 1489 | 214 | 25 | 28611215 |
| Pubmed | TRIO MYO9A LUZP1 BAIAP2L1 DDHD2 RASAL2 KIF26B PPFIBP1 TP53BP2 | 6.51e-06 | 209 | 214 | 9 | 36779422 | |
| Pubmed | MAP1B TRIO TSG101 KIAA0753 LPIN1 QSOX1 TBC1D1 RASAL2 RNF169 KIF26B ZSCAN5A PPFIBP1 RLIM ZFYVE19 ROBO2 DNAH11 | 6.58e-06 | 689 | 214 | 16 | 36543142 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UBR1 NCOA6 TRRAP SPICE1 QSOX1 YAP1 MAD1L1 PLCB3 DNMBP NOTCH2 DNMT1 RNF169 GEMIN5 MED1 LMO7 PCBP1 AKAP1 | 6.98e-06 | 774 | 214 | 17 | 15302935 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | GATAD2A MECOM SIX4 BAIAP2L1 SYNE2 DNMT1 TSHZ3 RBL2 GEMIN5 JMJD1C TSHZ1 ATP5F1B | 7.57e-06 | 398 | 214 | 12 | 35016035 |
| Pubmed | Yap/Taz mediates mTORC2-stimulated fibroblast activation and kidney fibrosis. | 7.90e-06 | 7 | 214 | 3 | 30154246 | |
| Pubmed | 7.90e-06 | 7 | 214 | 3 | 26121028 | ||
| Pubmed | 7.90e-06 | 7 | 214 | 3 | 31178125 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | LUZP1 MRTFB BAIAP2L1 YAP1 CRYBG1 PLCB3 PLEKHA7 GOLGB1 NOTCH2 PPFIBP1 LMO7 PCBP1 PCBP2 TP53BP2 | 1.23e-05 | 565 | 214 | 14 | 25468996 |
| Pubmed | INPP4A MECOM LUZP1 MRTFB SATB1 GOLGB1 TSHZ3 GEMIN5 JMJD1C AKAP1 TP53BP2 PCNT | 1.24e-05 | 418 | 214 | 12 | 34709266 | |
| Pubmed | An N-ethyl-N-nitrosourea screen for genes involved in variegation in the mouse. | 1.26e-05 | 8 | 214 | 3 | 15890782 | |
| Pubmed | 1.29e-05 | 83 | 214 | 6 | 28794006 | ||
| Pubmed | TRIO ITGA4 BAIAP2L1 PLEKHA7 GOLGB1 NOTCH2 RASAL2 PPFIBP1 OCRL CELSR2 MAP4K5 ROBO2 | 1.33e-05 | 421 | 214 | 12 | 36976175 | |
| Pubmed | Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms. | 1.59e-05 | 25 | 214 | 4 | 27340223 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.70e-05 | 180 | 214 | 8 | 35198878 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NCOA6 GATAD2A MECOM SIX4 TRRAP YAP1 DNMT1 RNF169 DR1 ZSCAN5A SMCHD1 NSD1 HEATR1 MED1 JMJD1C LMO7 NOM1 ZFP64 PCBP1 PCBP2 ATP5F1B HELLS | 1.81e-05 | 1294 | 214 | 22 | 30804502 |
| Pubmed | 1.88e-05 | 9 | 214 | 3 | 20439742 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | GATAD2A MAP1B LUZP1 SATB1 COG1 RNF169 SMCHD1 CPS1 MED1 JMJD1C PCBP1 HELLS | 2.24e-05 | 444 | 214 | 12 | 34795231 |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | ITGA4 SH3BP4 BAIAP2L1 ARHGAP31 SLC23A2 NOTCH2 RASAL2 IGSF3 KIF26B PPFIBP1 MAP4K5 | 2.46e-05 | 377 | 214 | 11 | 38117590 |
| Pubmed | 2.54e-05 | 28 | 214 | 4 | 25089626 | ||
| Pubmed | Evc regulates a symmetrical response to Shh signaling in molar development. | 2.67e-05 | 10 | 214 | 3 | 23315474 | |
| Pubmed | Essential role for Sonic hedgehog during hair follicle morphogenesis. | 2.67e-05 | 10 | 214 | 3 | 9882493 | |
| Pubmed | SH3BP4 BAIAP2L1 GOLGB1 NOTCH2 RASAL2 IGSF3 DNMT1 KRT14 KRT17 PPFIBP1 PODXL2 OCRL NOM1 AKAP1 PCDH9 HELLS | 2.86e-05 | 777 | 214 | 16 | 35844135 | |
| Pubmed | TRIO SIX4 LUZP1 SPICE1 KIAA0753 SYNE2 MTMR3 PLEKHA7 DNMT1 PPP4R1 RNF169 KRT14 PTPMT1 KRT17 PPM1E CDC25A TP53BP2 PCNT HELLS | 2.96e-05 | 1049 | 214 | 19 | 27880917 | |
| Pubmed | 3.65e-05 | 11 | 214 | 3 | 36654301 | ||
| Pubmed | FOXO3-mTOR metabolic cooperation in the regulation of erythroid cell maturation and homeostasis. | 3.77e-05 | 2 | 214 | 2 | 24966026 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 7607214 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 24168496 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 34343821 | ||
| Pubmed | Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex. | 3.77e-05 | 2 | 214 | 2 | 25288394 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 29780826 | ||
| Pubmed | Splicing factor poly(rC)-binding protein 1 is a novel and distinctive tumor suppressor. | 3.77e-05 | 2 | 214 | 2 | 30132844 | |
| Pubmed | Gli1 interacts with YAP1 to promote tumorigenesis in esophageal squamous cell carcinoma. | 3.77e-05 | 2 | 214 | 2 | 31957872 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 29545197 | ||
| Pubmed | Identification of two KH domain proteins in the alpha-globin mRNP stability complex. | 3.77e-05 | 2 | 214 | 2 | 7556077 | |
| Pubmed | Functional analyses of Pericentrin and Syne-2 interaction in ciliogenesis. | 3.77e-05 | 2 | 214 | 2 | 30054381 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 35595017 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 20071580 | ||
| Pubmed | Tissue-specific inactivation of HAT cofactor TRRAP reveals its essential role in B cells. | 3.77e-05 | 2 | 214 | 2 | 24675885 | |
| Pubmed | Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis. | 3.77e-05 | 2 | 214 | 2 | 31296961 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 19181385 | ||
| Pubmed | Histone demethylase JMJD1C is phosphorylated by mTOR to activate de novo lipogenesis. | 3.77e-05 | 2 | 214 | 2 | 32034158 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 14500757 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 10455157 | ||
| Pubmed | ULK4 and Fused/STK36 interact to mediate assembly of a motile flagellum. | 3.77e-05 | 2 | 214 | 2 | 36989043 | |
| Pubmed | YAP accelerates vascular senescence via blocking autophagic flux and activating mTOR. | 3.77e-05 | 2 | 214 | 2 | 33314583 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 25746967 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 35151693 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 25360797 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 28541550 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 16828057 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 24094292 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 11025204 | ||
| Pubmed | αCP Poly(C) binding proteins act as global regulators of alternative polyadenylation. | 3.77e-05 | 2 | 214 | 2 | 23629627 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 24123876 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 30841479 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 12414943 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 16431949 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 2433272 | ||
| Pubmed | Aberrant antibody affinity selection in SHIP-deficient B cells. | 3.77e-05 | 2 | 214 | 2 | 23135975 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 14715907 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 32391547 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 26896798 | ||
| Pubmed | High glucose mediates NLRP3 inflammasome activation via upregulation of ELF3 expression. | 3.77e-05 | 2 | 214 | 2 | 32439949 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 34826200 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 38920017 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 8855318 | ||
| Pubmed | Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas. | 3.77e-05 | 2 | 214 | 2 | 28759011 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 17568789 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 20871598 | ||
| Pubmed | Screening diagnostic biomarkers of OSCC via an LCM-based proteomic approach. | 3.77e-05 | 2 | 214 | 2 | 30066921 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 21458454 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 33689703 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 34473651 | ||
| Pubmed | mTOR regulates NLRP3 inflammasome activation via reactive oxygen species in murine lupus. | 3.77e-05 | 2 | 214 | 2 | 30060081 | |
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 21752917 | ||
| Pubmed | 3.77e-05 | 2 | 214 | 2 | 32647012 | ||
| Pubmed | 3.85e-05 | 31 | 214 | 4 | 29099309 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.88e-05 | 202 | 214 | 8 | 33005030 | |
| Pubmed | 4.38e-05 | 32 | 214 | 4 | 16516881 | ||
| Pubmed | 4.40e-05 | 103 | 214 | 6 | 10574462 | ||
| Pubmed | 4.85e-05 | 12 | 214 | 3 | 21746835 | ||
| Interaction | YWHAH interactions | NCOA6 RIN3 NCKAP1 TRIO MYO9A KIAA0232 LUZP1 KIAA0753 SH3BP4 BAIAP2L1 YAP1 TBC1D1 SYNE2 MAD1L1 MTMR3 DNMBP PLEKHA7 NOTCH2 RASAL2 DNMT1 OARD1 FOXO3 EVC2 KIF26B PPFIBP1 MED1 FAM86C1P LMO7 MTOR PLEKHA3 CDC25A AKAP1 TP53BP2 PCNT | 7.43e-09 | 1102 | 206 | 34 | int:YWHAH |
| Interaction | YWHAG interactions | NCOA6 NCKAP1 MYO9A KIAA0232 ITGA4 TRRAP LUZP1 SPICE1 KIAA0753 SH3BP4 LPIN1 BAIAP2L1 YAP1 TBC1D1 SYNE2 MAD1L1 MTMR3 DNMBP PLEKHA7 NOTCH2 RASAL2 DNMT1 FOXO3 KIF26B PPFIBP1 FAM86C1P LMO7 MTOR MAP4K5 PLEKHA3 CDC25A TP53BP2 ATP5F1B | 4.68e-07 | 1248 | 206 | 33 | int:YWHAG |
| Interaction | KRT19 interactions | ITGA4 ARHGEF11 LUZP1 SPICE1 KIAA0753 YAP1 DNMBP KRT12 KRT14 IKZF3 KRT17 CEP164 TP53BP2 PCNT | 1.32e-06 | 282 | 206 | 14 | int:KRT19 |
| Interaction | GJA1 interactions | MAP1B TRIO TSG101 THSD1 SH3BP4 COG1 SYNE2 NINJ2 PLEKHA7 GOLGB1 NOTCH2 RASAL2 PPFIBP1 OCRL TSPAN10 MAP4K5 ROBO2 PCDH9 ATP5F1B | 9.19e-06 | 583 | 206 | 19 | int:GJA1 |
| Interaction | YWHAQ interactions | NCOA6 RIN3 NCKAP1 MYO9A LUZP1 SH3BP4 YAP1 TBC1D1 ULK4 DNMBP PLEKHA7 GOLGB1 RASAL2 DNMT1 FOXO3 KRT17 KIF26B PPFIBP1 CPS1 MED1 FAM86C1P LMO7 MTOR PLEKHA3 CDC25A PCBP1 TP53BP2 ATP5F1B | 1.06e-05 | 1118 | 206 | 28 | int:YWHAQ |
| Interaction | YWHAZ interactions | BDP1 RIN3 NCKAP1 MYO9A KIAA0232 ITGA4 LUZP1 SH3BP4 ANKRD34B BAIAP2L1 YAP1 TBC1D1 SYNE2 MTMR3 DNMBP PLEKHA7 RASAL2 DNMT1 FOXO3 KRT17 KIF26B PPFIBP1 FAM86C1P LMO7 MTOR PLEKHA3 ZFYVE19 CDC25A TP53BP2 ATP5F1B PCNT | 1.21e-05 | 1319 | 206 | 31 | int:YWHAZ |
| Cytoband | 2p13-p12 | 1.29e-04 | 4 | 214 | 2 | 2p13-p12 | |
| Cytoband | 1p36.21 | 2.20e-04 | 63 | 214 | 4 | 1p36.21 | |
| GeneFamily | PRAME family | 1.38e-06 | 24 | 150 | 5 | 686 | |
| GeneFamily | Phosphoinositide phosphatases | 6.18e-06 | 32 | 150 | 5 | 1079 | |
| GeneFamily | Dyneins, axonemal | 9.96e-06 | 17 | 150 | 4 | 536 | |
| GeneFamily | Ankyrin repeat domain containing | ACAP1 ANKS4B TRANK1 ANKRD34B ANKIB1 NOTCH2 ANKRD35 ASAP3 ANKS3 TP53BP2 | 3.49e-05 | 242 | 150 | 10 | 403 |
| GeneFamily | Olfactory receptors, family 3 | 1.00e-03 | 6 | 150 | 2 | 150 | |
| GeneFamily | Keratins, type I | 1.57e-03 | 28 | 150 | 3 | 608 | |
| Coexpression | BILBAN_B_CLL_LPL_UP | 7.83e-07 | 64 | 209 | 7 | M19930 | |
| Coexpression | GSE27896_HDAC6_KO_VS_WT_TREG_UP | 1.26e-05 | 176 | 209 | 9 | M8248 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCKAP1 MAP1B TRIO MECOM TRRAP YAP1 SYNE2 MAD1L1 MTMR3 DNMBP SLC23A2 FOXO3 TRIM2 SMCHD1 MED1 XRCC4 MAP4K5 TMEM131 TP53BP2 PCNT | 1.87e-05 | 856 | 209 | 20 | M4500 |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | ABCA3 TRIO SCRN1 NOTCH2 RASAL2 IGSF3 EVC2 NSD1 OCRL MED1 XRCC4 | 3.32e-09 | 200 | 211 | 11 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 3.56e-08 | 196 | 211 | 10 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 3.56e-08 | 196 | 211 | 10 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | BAL-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.30e-08 | 200 | 211 | 10 | 0cc7ff7b6a4eb05d2370ec2f3b9dbfe8cb0699de | |
| ToppCell | BAL-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.30e-08 | 200 | 211 | 10 | b762bf6f432eac05a476f6e2ab4da27dd13a2317 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.30e-08 | 200 | 211 | 10 | 4c63204e0d868dd4c11c1604a238624a3ad54485 | |
| ToppCell | Severe_COVID-19-Epithelial|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 4.30e-08 | 200 | 211 | 10 | 49910efb6d888c208cd50530b03af19f87070630 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.30e-08 | 200 | 211 | 10 | b9cede2e0939c6b60ce1aa16d7efaaae79354580 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-07 | 184 | 211 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-07 | 184 | 211 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-07 | 184 | 211 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.85e-07 | 187 | 211 | 9 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-07 | 188 | 211 | 9 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.56e-07 | 192 | 211 | 9 | a7ccbea7c90c070d279d7ad3f2b5b7c0e3efd890 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 4.06e-07 | 195 | 211 | 9 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 4.06e-07 | 195 | 211 | 9 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-07 | 197 | 211 | 9 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | BL-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.61e-07 | 198 | 211 | 9 | 6218a25b94d5fa2c69880539adf9c63bfe52dcd3 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 4.81e-07 | 199 | 211 | 9 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Severe-Epithelial-Epithelial-|Severe / Condition, Lineage, Cell class and cell subclass | 5.02e-07 | 200 | 211 | 9 | 8669ce08f93eefb8ac970e30cdc4b1f908023c54 | |
| ToppCell | Severe-Epithelial|Severe / Condition, Lineage, Cell class and cell subclass | 5.02e-07 | 200 | 211 | 9 | 6ead9db88568bb829d564a6d8e85f71fd765bac0 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.02e-07 | 200 | 211 | 9 | f5bc7d30aa03dd0f95eb64255bd1a2543be8d327 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.02e-07 | 200 | 211 | 9 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Severe-Epithelial-Epithelial|Severe / Condition, Lineage, Cell class and cell subclass | 5.02e-07 | 200 | 211 | 9 | 3bd1ce2793651c9badd69f011d2531183594e5f4 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_macrophage-Langerhans_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.44e-07 | 154 | 211 | 8 | 617ad0929d2ac0eeb7b8d9b0cba687176e684ed0 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 9.47e-07 | 159 | 211 | 8 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.57e-06 | 170 | 211 | 8 | cc66ac6846c58be9493eb270644ee3ce0f86cfea | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-06 | 178 | 211 | 8 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-06 | 181 | 211 | 8 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.51e-06 | 127 | 211 | 7 | 5b0adbcafad31a6759c9bdce2f7f9591a8edc450 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-06 | 183 | 211 | 8 | 544939a0bfef082d361d88ef70d6f0923b8d9af9 | |
| ToppCell | COVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type | 2.71e-06 | 183 | 211 | 8 | 5c7597a5b2bf6a481ca2c7e68560179214150fa0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-06 | 184 | 211 | 8 | 8fa7aa2a954f66576ada56670b4e1bb122864761 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-06 | 184 | 211 | 8 | b5fbfcf8516c2dc20dffc36803692505a63f1297 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-06 | 186 | 211 | 8 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.06e-06 | 186 | 211 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Immune-B_cell|World / Lineage, Cell type, age group and donor | 3.18e-06 | 187 | 211 | 8 | 795690c6306c366e733279491138d0cd9b469b21 | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 3.18e-06 | 187 | 211 | 8 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.18e-06 | 187 | 211 | 8 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-06 | 187 | 211 | 8 | 8fa454dc4e6a3e8e2bb2ad803acc579e0d3f76da | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-06 | 187 | 211 | 8 | edad646d5eb1d70b768dc21fe02ef5265214e8e6 | |
| ToppCell | (1)_T_CD4_naive|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.31e-06 | 188 | 211 | 8 | b8f67ac2faadd5b848955e43ab5d6cf5e49b3681 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.31e-06 | 188 | 211 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.31e-06 | 188 | 211 | 8 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 3.31e-06 | 188 | 211 | 8 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-06 | 189 | 211 | 8 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.44e-06 | 189 | 211 | 8 | 5a9e2ca9a9ee2dc37ab9147a902115a9f1a80169 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 3.58e-06 | 190 | 211 | 8 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.58e-06 | 190 | 211 | 8 | 424550418c1bd4eb070cf3c41cf09fa9d89aef37 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.72e-06 | 191 | 211 | 8 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.72e-06 | 191 | 211 | 8 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.72e-06 | 191 | 211 | 8 | 84452125d1b5b76974e3f9126f611eff16d45c25 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.72e-06 | 191 | 211 | 8 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 3.72e-06 | 191 | 211 | 8 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.72e-06 | 191 | 211 | 8 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class (2021.01.30) | 3.72e-06 | 191 | 211 | 8 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.72e-06 | 191 | 211 | 8 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.72e-06 | 191 | 211 | 8 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-06 | 193 | 211 | 8 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.02e-06 | 193 | 211 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.02e-06 | 193 | 211 | 8 | d371403b51281a6e37652fa8dc1b2dd81d2ab371 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.02e-06 | 193 | 211 | 8 | 3cde93bbfc1ae6fb586ae6b7aaa6ed8b5eee28a4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.02e-06 | 193 | 211 | 8 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.02e-06 | 193 | 211 | 8 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-06 | 193 | 211 | 8 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.02e-06 | 193 | 211 | 8 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.02e-06 | 193 | 211 | 8 | 6436d3bfce02d137b76e5c4c8b2fe27974c57c99 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.02e-06 | 193 | 211 | 8 | d755dc6de4fbd4d8f5d8a88aac497e7b9e8b89de | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 4.18e-06 | 194 | 211 | 8 | 2a144a1c2d537c8a59aa419206ddd96c23f0aeab | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 4.34e-06 | 195 | 211 | 8 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 4.68e-06 | 197 | 211 | 8 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 4.68e-06 | 197 | 211 | 8 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 4.68e-06 | 197 | 211 | 8 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.85e-06 | 198 | 211 | 8 | a4543d636501a1b5b46c14a661ce9d169947c82c | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.85e-06 | 198 | 211 | 8 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.85e-06 | 198 | 211 | 8 | 7608f67959e1cda7b10e57fd3af2f96216ebe7e9 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.04e-06 | 199 | 211 | 8 | 1df69c0cb5f759f6a2152521842506a75bb95cae | |
| ToppCell | Mild-Epithelial-Epithelial-|Mild / Condition, Lineage, Cell class and cell subclass | 5.04e-06 | 199 | 211 | 8 | 81115bbd2c10bfdd38376d2075f03a59c31870d2 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.04e-06 | 199 | 211 | 8 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 5.04e-06 | 199 | 211 | 8 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.04e-06 | 199 | 211 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.04e-06 | 199 | 211 | 8 | 74087b4b5e567310fc4ac58fb267ff651a180680 | |
| ToppCell | Mild-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 5.04e-06 | 199 | 211 | 8 | ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.04e-06 | 199 | 211 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.04e-06 | 199 | 211 | 8 | 1ee4010d8557564e25e8ee00b914c2dfd9037838 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.04e-06 | 199 | 211 | 8 | 00b5ce099c50a5e1786ce2b3a06ee0931a8205a4 | |
| ToppCell | PSB-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.04e-06 | 199 | 211 | 8 | 58dcb0eedafa8629585dc99e53147e2287f49689 | |
| ToppCell | Mild-Epithelial-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 5.04e-06 | 199 | 211 | 8 | 91308b255783ad4029e5575028c18d7550832c51 | |
| ToppCell | Bronchial_Biopsy-Epithelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.04e-06 | 199 | 211 | 8 | ef5d8917c8d011184830a0b8197afc6266707b37 | |
| ToppCell | Mild_COVID-19-Epithelial|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 5.04e-06 | 199 | 211 | 8 | 72689bda7476930887ae007682fcab27f956f050 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 5.23e-06 | 200 | 211 | 8 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 5.23e-06 | 200 | 211 | 8 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Biopsy_IPF-Epithelial|Biopsy_IPF / Sample group, Lineage and Cell type | 5.23e-06 | 200 | 211 | 8 | 76f1ac00b34d07057d8da03d276438b719b46b1d | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.23e-06 | 200 | 211 | 8 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD8+_T_naive|Control / Disease, condition lineage and cell class | 5.23e-06 | 200 | 211 | 8 | 906de95adc9716982ab32f216dddeb52639bad06 | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-mDC|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.60e-06 | 147 | 211 | 7 | 26bd9d89e2e7b841cc18030bb7cebb642b987183 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.74e-06 | 156 | 211 | 7 | 25b0936960be4955b6a6d6b8a867fdd4be548f05 | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.08e-05 | 105 | 211 | 6 | 76b73bc9236030e0703868fa8f7ecee2affe565b | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.08e-05 | 105 | 211 | 6 | 96566c83999aa625c84a4ed18a6df9daa99f9578 | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.08e-05 | 105 | 211 | 6 | bfd3395c51a0e868aa92eac4e929de59a3fe8b50 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.26e-05 | 49 | 115 | 6 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Disease | reticulocyte count | NCOA6 GATAD2A INPP5D ITGA4 STAC2 YAP1 SYNE2 MTMR3 PLCB3 PLEKHA7 SLC23A2 DNMT1 FOXO3 USP49 SEMA4D TRIM2 GEMIN5 JMJD1C RHCE MAP4K5 DNAH17 TMEM131 ATP5F1B PDZD2 | 1.82e-07 | 1045 | 199 | 24 | EFO_0007986 |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 6.25e-07 | 144 | 199 | 9 | EFO_0004611, EFO_0020943 | |
| Disease | Malignant neoplasm of breast | NCOA6 ACAP1 ABCA3 MECOM SIX4 FSCB CLCN1 YAP1 GLI1 SYNE2 MTMR3 DNAH9 GOLGB1 NOTCH2 RASAL2 DNMT1 KRT14 PPM1E NLRP9 MTOR ZFP64 TP53BP2 | 3.94e-06 | 1074 | 199 | 22 | C0006142 |
| Disease | platelet component distribution width | RIN3 NUP210L KIAA0232 MECOM EXD3 TRANK1 NINJ2 FOXO3 USP49 TFEC CRTAC1 CPS1 SCGN TEX11 JMJD1C RHCE DAPP1 ATP5F1B | 4.08e-06 | 755 | 199 | 18 | EFO_0007984 |
| Disease | Colorectal Carcinoma | CHL1 ACAP1 ABCA3 MAP1B LPIN1 YAP1 MCM3AP ABCD2 RASAL2 TFEC EVC2 ZSCAN5A PPM1E ASAP3 PPOX OVGP1 LMO7 | 6.23e-06 | 702 | 199 | 17 | C0009402 |
| Disease | bilirubin measurement | UBR1 INPP5D BAIAP2L1 MTMR3 DNMBP GPAT3 CPS1 JMJD1C NLRP3 RHCE MAP4K5 DNAH11 | 5.09e-05 | 442 | 199 | 12 | EFO_0004570 |
| Disease | reticulocyte measurement | GATAD2A INPP5D ITGA4 SYNE2 MTMR3 PLCB3 PLEKHA7 SLC23A2 DNMT1 FOXO3 SEMA4D TRIM2 JMJD1C RHCE MAP4K5 DNAH17 TMEM131 ATP5F1B PDZD2 | 1.01e-04 | 1053 | 199 | 19 | EFO_0010700 |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.12e-04 | 215 | 199 | 8 | EFO_0008317, EFO_0008591 | |
| Disease | cortical surface area measurement | RIN3 ATP8A2 MECOM LUZP1 ADAMTS9 ARHGAP31 PLEKHA7 FOXO3 STX8 SEMA4D TRIM2 KRT17 KIF26B PPFIBP1 FAT3 CRTAC1 MSH5 CPS1 ROBO2 PCBP2 PDZD2 DNAH11 | 1.18e-04 | 1345 | 199 | 22 | EFO_0010736 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.73e-04 | 229 | 199 | 8 | EFO_0004639, EFO_0008317 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.76e-04 | 121 | 199 | 6 | EFO_0008595, EFO_0020943 | |
| Disease | IGF-1 measurement, IGFBP-3 measurement | 1.92e-04 | 17 | 199 | 3 | EFO_0004626, EFO_0004627 | |
| Disease | alkaline phosphatase measurement | ACAP1 RIN3 PSKH1 ITIH3 KIRREL3 TRANK1 BAIAP2L1 YAP1 GOLGB1 DNMT1 DR1 TRIM2 RBL2 CPS1 FHIP2A JMJD1C NLRP3 MAP4K5 | 1.92e-04 | 1015 | 199 | 18 | EFO_0004533 |
| Disease | cortical thickness | RIN3 GATAD2A NUP210L MECOM LUZP1 ADAMTS9 MTMR3 PLEKHA7 FOXO3 STX8 SEMA4D PPFIBP1 FAT3 JMJD1C TSPAN10 ROBO2 TMEM131 ULK2 PDZD2 | 2.06e-04 | 1113 | 199 | 19 | EFO_0004840 |
| Disease | Intellectual Disability | MYT1L CHL1 MAP1B TRIO INPP4A ATP8A2 TRRAP NSD1 FHIP2A MTOR RLIM | 2.45e-04 | 447 | 199 | 11 | C3714756 |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 2.54e-04 | 307 | 199 | 9 | EFO_0004612, EFO_0020946 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 2.59e-04 | 243 | 199 | 8 | EFO_0004612, EFO_0020944 | |
| Disease | Ellis-Van Creveld Syndrome | 2.69e-04 | 4 | 199 | 2 | C0013903 | |
| Disease | urinary sodium to creatinine ratio | 2.69e-04 | 4 | 199 | 2 | EFO_0009883 | |
| Disease | hydrocephalus (implicated_via_orthology) | 2.70e-04 | 19 | 199 | 3 | DOID:10908 (implicated_via_orthology) | |
| Disease | citrulline measurement | 3.16e-04 | 20 | 199 | 3 | EFO_0009777 | |
| Disease | cholelithiasis | 3.30e-04 | 88 | 199 | 5 | EFO_0004799 | |
| Disease | Schizophrenia | MYT1L CHL1 ARHGEF11 TRRAP ITIH3 PRODH2 CLVS2 MAD1L1 ULK4 DNMT1 DDR1 XRCC4 MTOR HTR3B PRL PCNT | 3.46e-04 | 883 | 199 | 16 | C0036341 |
| Disease | neuroimaging measurement | GATAD2A MAP1B ARHGEF11 LUZP1 STAC2 PLEKHA7 FOXO3 SEMA4D KRT17 KIF26B FAT3 RNF34 MSH5 XRCC4 JMJD1C RLIM ROBO2 DNAH11 | 3.58e-04 | 1069 | 199 | 18 | EFO_0004346 |
| Disease | pain | 3.86e-04 | 196 | 199 | 7 | EFO_0003843 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 4.36e-04 | 200 | 199 | 7 | EFO_0004611, EFO_0020945 | |
| Disease | thrombospondin type-1 domain-containing protein 1 measurement | 4.47e-04 | 5 | 199 | 2 | EFO_0802131 | |
| Disease | insulin-like growth factor-binding protein 1 measurement | 4.47e-04 | 5 | 199 | 2 | EFO_0020474 | |
| Disease | monocyte percentage of leukocytes | ACAP1 KIAA0232 MECOM ITGA4 ARHGEF11 BAIAP2L1 TBC1D1 MCM3AP ULK4 NINJ2 ZSCAN5A JMJD1C NLRP3 MAP4K5 | 4.73e-04 | 731 | 199 | 14 | EFO_0007989 |
| Disease | Metastatic melanoma | 4.88e-04 | 54 | 199 | 4 | C0278883 | |
| Disease | cancer (implicated_via_orthology) | 4.97e-04 | 268 | 199 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | serum gamma-glutamyl transferase measurement | UBR1 MYO9A NUP210L ARHGEF11 TRANK1 DNMBP NOTCH2 DNMT1 FOXO3 IKZF3 ASAP3 CPS1 JMJD1C CELSR2 MAP4K5 TSHZ1 | 5.03e-04 | 914 | 199 | 16 | EFO_0004532 |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 6.02e-04 | 276 | 199 | 8 | EFO_0004612, EFO_0020943 | |
| Disease | fibrinogen measurement, factor VII measurement | 6.41e-04 | 58 | 199 | 4 | EFO_0004619, EFO_0004623 | |
| Disease | apolipoprotein A 1 measurement | PSKH1 TRANK1 GLI1 PLCB3 SEMA4D DR1 TRIM2 NSD1 CRTAC1 CPS1 JMJD1C CEP164 CELSR2 FEZ2 MAP4K5 | 6.77e-04 | 848 | 199 | 15 | EFO_0004614 |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 6.80e-04 | 103 | 199 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | triglycerides to total lipids in small LDL percentage | 6.84e-04 | 59 | 199 | 4 | EFO_0022337 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 6.84e-04 | 59 | 199 | 4 | EFO_0022248 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 7.29e-04 | 60 | 199 | 4 | C4722327 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 7.67e-04 | 220 | 199 | 7 | EFO_0004529, EFO_0008317 | |
| Disease | platelet crit | RIN3 GATAD2A NUP210L MECOM ARHGEF11 SH3BP4 MAD1L1 NINJ2 RASAL2 TFEC CPS1 SCGN JMJD1C NLRP3 RHCE MAP4K5 | 7.77e-04 | 952 | 199 | 16 | EFO_0007985 |
| Disease | gallstones | 8.43e-04 | 108 | 199 | 5 | EFO_0004210 | |
| Disease | serum alanine aminotransferase measurement | CHL1 NDST4 TRANK1 ADAMTS9 YAP1 DNMBP DNMT1 FOXO3 CRTAC1 CPS1 NLRP3 CELSR2 MAP4K5 PLEKHA3 ATP5F1B | 8.67e-04 | 869 | 199 | 15 | EFO_0004735 |
| Disease | group XIIB secretory phospholipase A2-like protein measurement | 9.29e-04 | 7 | 199 | 2 | EFO_0801657 | |
| Disease | lymphocyte count | ACAP1 KIAA0232 ITGA4 ARHGEF11 BAIAP2L1 ARHGAP31 TBC1D1 MCM3AP NINJ2 DDHD2 NOTCH2 DNMT1 MIER2 IKZF3 PCDHGC5 NSD1 CPS1 JMJD1C MAP4K5 DNAH17 ROBO2 | 9.47e-04 | 1464 | 199 | 21 | EFO_0004587 |
| Disease | cholesterol in large VLDL measurement | 9.85e-04 | 65 | 199 | 4 | EFO_0021902 | |
| Disease | total lipids in large VLDL | 1.10e-03 | 67 | 199 | 4 | EFO_0022175 | |
| Disease | ceramide measurement | 1.13e-03 | 235 | 199 | 7 | EFO_0010222 | |
| Disease | free cholesterol in large VLDL measurement | 1.17e-03 | 68 | 199 | 4 | EFO_0022265 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 1.18e-03 | 31 | 199 | 3 | EFO_0022249 | |
| Disease | calcium measurement | NCOA6 STAC2 KIRREL3 YAP1 SYNE2 GOLGB1 ASAP3 CPS1 CELSR2 MAP4K5 TMEM131 AKAP1 | 1.22e-03 | 628 | 199 | 12 | EFO_0004838 |
| Disease | pulse pressure measurement | RIN3 GATAD2A NCKAP1 MAP1B ITIH3 LUZP1 KIAA0753 QSOX1 TRANK1 YAP1 ULK4 DDHD2 PLEKHA7 DNMT1 FOXO3 FAT3 CRTAC1 MSH5 CEP164 CDC25A | 1.23e-03 | 1392 | 199 | 20 | EFO_0005763 |
| Disease | Prostate cancer, familial | 1.23e-03 | 69 | 199 | 4 | C2931456 | |
| Disease | level of Triacylglycerol (49:2) in blood serum | 1.23e-03 | 8 | 199 | 2 | OBA_2045162 | |
| Disease | body surface area | LUZP1 MTMR3 ULK4 DNMT1 FOXO3 SMCHD1 NSD1 CRTAC1 CPS1 FEZ2 MTOR MAP4K5 | 1.48e-03 | 643 | 199 | 12 | EFO_0022196 |
| Disease | X-21467 measurement | 1.58e-03 | 9 | 199 | 2 | EFO_0020007 | |
| Disease | visceral adipose tissue measurement | ULK4 CRYBG1 FOXO3 SEMA4D TFEC CRTAC1 MON1A MTOR SPHKAP ROBO2 | 1.67e-03 | 481 | 199 | 10 | EFO_0004765 |
| Disease | behavioural disinhibition measurement | 1.68e-03 | 75 | 199 | 4 | EFO_0006946 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.68e-03 | 75 | 199 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 1.73e-03 | 127 | 199 | 5 | EFO_0008595, EFO_0020947 | |
| Disease | granulocyte count | 1.76e-03 | 254 | 199 | 7 | EFO_0007987 | |
| Disease | macula measurement | 1.84e-03 | 189 | 199 | 6 | EFO_0008375 | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 1.97e-03 | 10 | 199 | 2 | OBA_2045163 | |
| Disease | glucagon-like peptide-1 measurement | 1.97e-03 | 10 | 199 | 2 | EFO_0008465 | |
| Disease | very low density lipoprotein cholesterol measurement | 2.00e-03 | 260 | 199 | 7 | EFO_0008317 | |
| Disease | very low density lipoprotein particle size measurement | 2.12e-03 | 133 | 199 | 5 | EFO_0008594 | |
| Disease | Abnormality of refraction | ADAMTS9 CLVS2 MAD1L1 MTMR3 ULK4 SEMA4D TSHZ3 FAT3 MON1A TSPAN10 MAP4K5 PCDH9 | 2.17e-03 | 673 | 199 | 12 | HP_0000539 |
| Disease | Sepsis, mortality | 2.39e-03 | 11 | 199 | 2 | EFO_0004352, HP_0100806 | |
| Disease | level of Ceramide (d40:1) in blood serum | 2.39e-03 | 11 | 199 | 2 | OBA_2045185 | |
| Disease | Situs Inversus | 2.39e-03 | 11 | 199 | 2 | C0037221 | |
| Disease | serum albumin measurement | RIN3 GATAD2A MAD1L1 DR1 TRIM2 ASAP3 SCGN JMJD1C NLRP3 MAP4K5 PCNT | 2.40e-03 | 592 | 199 | 11 | EFO_0004535 |
| Disease | metabolic syndrome | 2.44e-03 | 200 | 199 | 6 | EFO_0000195 | |
| Disease | neutrophil count | ACAP1 RIN3 NUP210L INPP5D MECOM ITGA4 STAC2 BAIAP2L1 NOTCH2 DNMT1 NSD1 MON1A CPS1 LCT JMJD1C NLRP3 MAP4K5 PCNT HELLS | 2.66e-03 | 1382 | 199 | 19 | EFO_0004833 |
| Disease | AL amyloidosis | 2.86e-03 | 12 | 199 | 2 | MONDO_0019438 | |
| Disease | high grade glioma (is_marker_for) | 2.86e-03 | 42 | 199 | 3 | DOID:3070 (is_marker_for) | |
| Disease | fatty acid measurement | 2.96e-03 | 436 | 199 | 9 | EFO_0005110 | |
| Disease | depressive symptom measurement, response to antidepressant | 3.01e-03 | 88 | 199 | 4 | EFO_0007006, GO_0036276 | |
| Disease | neutrophil percentage of leukocytes | RIN3 ITGA4 BAIAP2L1 TBC1D1 NINJ2 USP49 LCT JMJD1C NLRP3 MAP4K5 TMEM131 | 3.01e-03 | 610 | 199 | 11 | EFO_0007990 |
| Disease | prostate carcinoma | TRIO MECOM SIX4 BAIAP2L1 CLVS2 SYNE2 MAD1L1 NSD1 TEX11 ARHGAP6 LMO7 TSHZ1 HTR3B DNAH11 | 3.03e-03 | 891 | 199 | 14 | EFO_0001663 |
| Disease | triglycerides in large LDL measurement | 3.06e-03 | 43 | 199 | 3 | EFO_0022319 | |
| Disease | urate measurement | NCOA6 MYO9A MECOM GLI1 PLCB3 DDHD2 NOTCH2 DR1 KRT17 NSD1 CPS1 JMJD1C MAP4K5 SLC16A10 | 3.16e-03 | 895 | 199 | 14 | EFO_0004531 |
| Disease | neutrophil count, eosinophil count | 3.33e-03 | 213 | 199 | 6 | EFO_0004833, EFO_0004842 | |
| Disease | Hodgkin lymphoma, lymphocyte depletion | 3.36e-03 | 13 | 199 | 2 | C0152267 | |
| Disease | Mixed Cellularity Hodgkin Lymphoma | 3.36e-03 | 13 | 199 | 2 | C0152266 | |
| Disease | Lymphocyte Rich Classical Hodgkin Lymphoma | 3.36e-03 | 13 | 199 | 2 | C1266194 | |
| Disease | Adult Hodgkin Lymphoma | 3.36e-03 | 13 | 199 | 2 | C0220597 | |
| Disease | Nodular Lymphocyte Predominant Hodgkin Lymphoma | 3.36e-03 | 13 | 199 | 2 | C1334968 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 3.48e-03 | 45 | 199 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 3.48e-03 | 45 | 199 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 3.48e-03 | 45 | 199 | 3 | EFO_0022236 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 3.57e-03 | 150 | 199 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.74e-03 | 291 | 199 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | cardiac troponin T measurement | 3.81e-03 | 219 | 199 | 6 | EFO_0005043 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 3.88e-03 | 153 | 199 | 5 | EFO_0004611, EFO_0020944 | |
| Disease | multiple myeloma, monoclonal gammopathy | 3.90e-03 | 14 | 199 | 2 | EFO_0000203, EFO_0001378 | |
| Disease | Primary Ciliary Dyskinesia | 3.94e-03 | 47 | 199 | 3 | C4551720 | |
| Disease | Squamous cell carcinoma of esophagus | 3.96e-03 | 95 | 199 | 4 | C0279626 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 3.96e-03 | 95 | 199 | 4 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | fibrinogen measurement, coronary artery disease | 3.99e-03 | 154 | 199 | 5 | EFO_0001645, EFO_0004623 | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 4.11e-03 | 96 | 199 | 4 | EFO_0004530, EFO_0008317, EFO_0008596 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LGSTFNLRMSDDPEQ | 376 | Q8NFU0 | |
| EGERELSPESLQAMA | 1481 | Q5RHP9 | |
| EGVNNDPDESMSSRI | 411 | A6H8Y1 | |
| ESSGILPNTTDMRLR | 106 | Q92667 | |
| SRMQSLTLDLLGPSE | 476 | Q8TDY4 | |
| MSRREGSLEDPQTDS | 1 | Q16619 | |
| TVRDTMSDLPEVRNG | 1366 | P26358 | |
| MSDLPEVRNGASALE | 1371 | P26358 | |
| QSLLNRMGDVTPEGT | 271 | O15254 | |
| GRLANPDQSLTEDIM | 201 | Q9UBJ2 | |
| LNAPARLGIMSSEEV | 251 | Q9NP70 | |
| NSSMFDEIREISLPL | 96 | O95264 | |
| GMQDRTIPDSDISAS | 36 | Q08345 | |
| SLMNRNSVLSDPGLD | 236 | O15085 | |
| EGLPSDRMSTENAAI | 3471 | Q96DT5 | |
| LILDEPTSGMDAISR | 686 | Q99758 | |
| SLMRLGAENDPFSTD | 921 | Q9P2G1 | |
| EETMALPQEGSLARI | 306 | Q6XZF7 | |
| GADDLVLTLSNPQMS | 36 | P78545 | |
| SEGRDPLTIAMETAN | 671 | Q15027 | |
| LDVLDNDGRTPLMIA | 146 | Q8N283 | |
| NRPLEAIMSVLVSDG | 1091 | Q9HCU4 | |
| RDTTDLSPGGTQEME | 6 | Q8TCP9 | |
| ENGVNSPRMDLTLAE | 116 | Q13625 | |
| TPAMARTSNLNEELG | 406 | Q9NTI2 | |
| LDSTSRIMDPNIVGS | 401 | P06576 | |
| QGSIPSTQEMEARLA | 211 | Q96K21 | |
| ELSPERLAEAMDSGQ | 261 | Q9UF12 | |
| DPDSSTSTLGNMLEL | 281 | Q96L73 | |
| APELAMGALELESRN | 561 | O00391 | |
| MGALELESRNSTLDP | 566 | O00391 | |
| ESMPLREGSSFQDLL | 131 | Q96HZ4 | |
| NGRMVLPVDESLTEA | 191 | Q96PE3 | |
| ATSQDQPLDLSMGSR | 766 | Q03112 | |
| TPTRLTGANSDMEEE | 986 | Q08999 | |
| INESNDRGETPLMIA | 36 | A5PLL1 | |
| MASSLNEDPEGSRIT | 1 | Q9Y530 | |
| LASDLNTDGDMRVTP | 36 | Q86YP4 | |
| MELTPSSATLGQEDL | 341 | Q9NZ53 | |
| LDPVLADRSATEMSG | 161 | A8MXZ1 | |
| DLDARMNDGTTPLIL | 1936 | Q04721 | |
| DMLPNSTERAITIAG | 136 | Q15365 | |
| LDRSDLIDQMNASGP | 801 | Q9NRZ9 | |
| VEAMSSQPALALDER | 1481 | P46821 | |
| DQTMGLSIRTPEDLS | 321 | Q9Y6D9 | |
| GFQITDRIAESLDMP | 161 | Q8TD90 | |
| MDAAPGVDLTRLLND | 286 | Q99456 | |
| GSLRSLNRDMQPTES | 1146 | O00533 | |
| LNRDMQPTESADSLV | 1151 | O00533 | |
| EARELQLSTAMETPA | 436 | Q5H9T9 | |
| TSMEPLDLSGAREAL | 216 | Q02846 | |
| RDLGQSNSDLDMPFA | 631 | Q86W92 | |
| EMDAAPGVDLSRILN | 271 | P02533 | |
| MAPEENAGSELLLQS | 1 | Q9NVL1 | |
| SPDNLLILSEMGDDS | 1336 | Q2KJY2 | |
| SGRTMPNILDDIIAS | 2101 | Q15652 | |
| PSTEDLMRGASAEEL | 1846 | O60318 | |
| LSGTMPFEDDNRTRL | 291 | P11801 | |
| LDPVLADRSATEMSG | 161 | A8MWA6 | |
| LDPVLADRSATEMSG | 161 | P0C7W9 | |
| PGASETMQGESRILN | 521 | Q92628 | |
| LPVSGQLDDATRARM | 66 | Q99542 | |
| LMEPEAGTNRTAVAE | 6 | P47893 | |
| LMEPEAGTNRTAVAE | 6 | P47888 | |
| PEREMRISESAASGA | 136 | Q9Y5F6 | |
| TMETPLDRNIGDSSQ | 791 | Q9HC56 | |
| LGQQPMTELDSSSDL | 1221 | O15018 | |
| MAPEENAGTELLLQS | 1 | Q96G04 | |
| DSNLFSLEMREPLES | 336 | Q8IXT1 | |
| SLEPMGSLSASLENQ | 956 | Q9ULH7 | |
| DSLNIVMDQGDTPTL | 376 | O94830 | |
| ERESSLPNGRSVSLM | 696 | Q9UJF2 | |
| RDQALAMSTLEELPT | 21 | P0DUQ1 | |
| NDQMIDILSSEDPGS | 361 | Q86UK5 | |
| DILSSEDPGSMLQAL | 366 | Q86UK5 | |
| LMSESGEGEISPQRE | 1016 | Q8WWI1 | |
| SPILSEGASRMECQL | 106 | Q14693 | |
| AMELLESSRTLPNDI | 191 | Q14693 | |
| TEVITNNGMPLARED | 1356 | P09848 | |
| GNMSVLLRSLPGETE | 1086 | P08151 | |
| NLSDEDGMTPTLLAA | 26 | Q8N8V4 | |
| IDGQQLRSDPATVMD | 766 | Q9H3R1 | |
| MASSSGNDDDLTIPR | 1 | Q01658 | |
| EMQGVELQPRLSGSD | 2466 | O95613 | |
| SDISEMRSLSELLGP | 831 | Q9Y2A7 | |
| DMLPNSTERAITIAG | 136 | Q15366 | |
| RMQSLSPVCSGLENE | 641 | Q8WY54 | |
| TMAEGRSEDNLSATP | 11 | Q96F15 | |
| MDQVASRALQDSSLP | 651 | Q2TAC6 | |
| LSERSLLAMQEDAAP | 676 | O43182 | |
| APGLMGTEQLSTELD | 1861 | Q14686 | |
| RLSTVDMTGIPTLDN | 96 | Q8WUK0 | |
| GPNMEVDTLDISSIR | 56 | Q01970 | |
| LDGTLTPSDGQSMER | 111 | Q86VX9 | |
| MGTSPLQIDRAEDRS | 1076 | P31327 | |
| TLLVRDLAEMGSPDA | 11 | Q9P2N4 | |
| TNDILAMLSPEGERV | 1251 | Q9C0G6 | |
| SNAELPVLMLGRSSD | 256 | P83105 | |
| EDTAGQTALTVMRPD | 936 | O75054 | |
| MDAAPGVDLSRILNE | 241 | Q04695 | |
| SSGPGEEALLQMRSN | 291 | O95393 | |
| MSRGPEEVNRLTEST | 1 | Q9UHR4 | |
| MLLEESSPRQALTDF | 216 | Q8WTW3 | |
| LDGTLESMERIPSSL | 171 | Q9UFH2 | |
| IRMELDEDGLTFNPT | 901 | Q9UFH2 | |
| SASVGIIQRDESPME | 66 | Q53EU6 | |
| VMETGLLLPRATAQD | 241 | P15391 | |
| TAMQTGRTEDDLVPT | 146 | Q9UN19 | |
| LRITATDGENLADPM | 651 | Q8TDW7 | |
| DQVAMRLSSNSGEDP | 571 | Q5T1N1 | |
| SRDEVMGDNLLLSSV | 116 | Q96L14 | |
| LLGSPMGSEQTRLDL | 661 | Q96BJ8 | |
| ITLQLAEAERMADGP | 851 | Q86V48 | |
| SDLLVGAPMQSTIRE | 321 | P13612 | |
| DEASEPELLNRSLSM | 6 | Q6ZW76 | |
| RAGLPLDTAETLDMA | 41 | Q8IXV7 | |
| RMTTEPQSLLVDLGS | 336 | Q8IZU9 | |
| MSLTTDDLLRLPADG | 121 | Q8IYD9 | |
| MDPEASDLSRGILAL | 211 | Q9NQ79 | |
| ELLADNINLGDPSSM | 666 | Q9H583 | |
| EGLPADRMSVENATI | 3441 | Q9NYC9 | |
| TVSEEEILPATRGMN | 346 | Q9Y4K1 | |
| EILPATRGMNGDSSE | 351 | Q9Y4K1 | |
| QSRQPEELSGATGME | 206 | Q5W0V3 | |
| LTRAEMSNGAPQELE | 346 | Q9UKT9 | |
| MAPEENAGTELLLQS | 1 | A6NEL3 | |
| MDSSREPTLGRLDAA | 1 | O76038 | |
| LDPVLADRSATEMSG | 161 | P0C7X0 | |
| LERQNSSSGSPRMEI | 666 | Q15648 | |
| DDETPTQSDRLSMLS | 181 | Q9UHY8 | |
| ETEARDEMGLSSDPN | 351 | Q9Y4K4 | |
| QDTLTGMRTDPLSVD | 391 | Q8N344 | |
| ARMLSSNERDSSEPG | 181 | P30304 | |
| ETRGPNVDSSTDMLV | 836 | Q13615 | |
| PLELMVRALDAEGNT | 146 | Q5VU65 | |
| EGQTMPLRGENLTSE | 586 | Q12889 | |
| VSERVSLEDQSPGMA | 391 | Q8TB24 | |
| LSRPAVQLLGDVMSE | 221 | Q96RQ9 | |
| RTLDQSPELRSTAMD | 1161 | P42345 | |
| RLPSMVEASDFEING | 451 | O43196 | |
| LDLSDNSLGDPGMRV | 746 | Q96P20 | |
| MESARENIDLQPGSS | 1 | Q9NZG7 | |
| LPSLQMADEESRLSA | 181 | P01236 | |
| SQMATRGLLDLDNPE | 146 | Q8TC99 | |
| SGRLSPIMASTELDE | 321 | O43524 | |
| LVDGLVRSSPSLDQM | 36 | Q8N2H4 | |
| MDGNSLLSVPSNLES | 1 | Q2M3C7 | |
| EIMSLVLAESSPGRD | 1571 | A6NHR9 | |
| EPAQLGMARDASLTL | 256 | Q9BX59 | |
| LDFVSQDEMLTPLGR | 36 | Q8TF05 | |
| NSTLSDSGMIDNLPD | 116 | Q9P0V3 | |
| PEERAGNQSMIALTT | 2656 | Q8WXH0 | |
| SLDSSRSEPMQQLLD | 61 | Q9H7V2 | |
| SLDLMQLRDESPGTS | 616 | Q5VVP1 | |
| IMLTDGDANVGESRP | 391 | Q06033 | |
| LDPVLADRSATEMSG | 161 | P0C7W8 | |
| MAADGVDERSPLLSA | 1 | Q8N4L2 | |
| PEFTDQGRSRSMLEV | 546 | Q6IQ23 | |
| RDQALAMSTLEELPT | 21 | A6NGN4 | |
| QRLQSMDTSGLPEEH | 166 | Q92835 | |
| TELNRDIADSQPMSA | 631 | Q9UIU6 | |
| RLSEPNMASISGQLE | 371 | Q5C9Z4 | |
| RDQALAMSTLEELPT | 21 | A3QJZ7 | |
| LSDSENEEPSRGQMT | 246 | Q8NCN4 | |
| ESPSRGLIQEMSGDA | 536 | Q92854 | |
| MLERPCNGNSLDESV | 846 | Q2KHM9 | |
| LDPVLADRSATEMSG | 161 | P0C7V4 | |
| SLLQMVPLDEGASER | 716 | Q01968 | |
| NTREPAAEIEALLGM | 96 | Q12765 | |
| DERERSLNAASAMGP | 446 | Q01826 | |
| SMVLRLPEEASAQEG | 886 | Q9NRP7 | |
| SLTPGSMEERIAELN | 721 | Q8N0Z3 | |
| ETRNLDPENGSGMAL | 326 | Q6ZMH5 | |
| SSVESGRQLGELMLP | 171 | Q9UPV0 | |
| LQPGIAMETRGLADS | 46 | Q16281 | |
| GELMPREAISTLFDN | 416 | P35523 | |
| TPSMLRLAIEGLQDS | 176 | Q5SYC1 | |
| DMENTSLDDPSLAIL | 636 | Q7RTR0 | |
| DGSSRELMNLTGTIP | 46 | Q99816 | |
| QRRLGPEVASLAMDS | 151 | P50336 | |
| RDQALAMSTLEELPT | 21 | O60810 | |
| ARGMELLSPEDLVNA | 276 | Q86VN1 | |
| EMAPLGATRESLRSQ | 136 | Q9NX65 | |
| EDNDQRATIPSLSAM | 196 | P18577 | |
| LDSTGSLDPQRSDMI | 76 | Q9UGH3 | |
| LENGTPDTAAMALER | 106 | Q99747 | |
| ELMDGDQTSRSGVPA | 196 | Q969K3 | |
| LALQPGDRIMLVDDS | 311 | Q6ZMT1 | |
| RDQALAMSTLEELPT | 21 | P0DUQ2 | |
| LMRDNNLLGTPGEST | 46 | Q9NVW2 | |
| SFGLTEAEQRMLDLP | 816 | Q9NS62 | |
| TEMLDFGTLRTQDLP | 326 | Q92545 | |
| AENMSLETLRNSSPE | 316 | Q13426 | |
| EELIDSSPLSDNQRM | 1066 | Q86TI0 | |
| ERGELTDNLVAMAPA | 941 | Q8TEQ6 | |
| TLRSMASGEDVVLPQ | 116 | Q70CQ1 | |
| ELPRSMASSETQLGN | 21 | Q9BUG6 | |
| MPSLQEALSSDILND | 471 | P46937 | |
| AGGTERMEISAELPQ | 6 | Q8IWV7 | |
| DGQELRTNPAASMES | 776 | P52849 | |
| SEDNDLVAERGSPTM | 526 | Q8IYF3 | |
| TNMVGERDSDPAELT | 206 | Q9HCK4 | |
| REAGEMESSTLQESP | 616 | Q2M1Z3 | |
| MESSTLQESPRARAE | 621 | Q2M1Z3 | |
| TSSDSMGETDNPRLL | 501 | Q04864 | |
| GAEPDLIRSSLMSEE | 101 | Q9UNK0 | |
| SGDPIANAVADMLRE | 236 | Q9NZQ9 | |
| NSPLRENALSDISDM | 836 | Q63HK5 | |
| DLASATIPEESRLMA | 271 | Q9HB20 | |
| QGSTDSLNTERPMDI | 686 | Q8IYT8 | |
| MEEGERSPLLSQETA | 1 | Q9H1Z9 | |
| RDSLGMDPQSRSLKN | 81 | O43247 | |
| EQRLDGMLLDDTISP | 301 | O14948 | |
| DSPGRNMDTALEELQ | 121 | Q8WTV1 | |
| LMDVLQRTPGSNAEE | 86 | Q9C040 | |
| TEDVQMLLRFGADPT | 261 | O15050 | |
| MRLVEDNPSSLSLVE | 3581 | Q9Y4A5 | |
| ITLPSEAREQMATLG | 281 | Q9NTW7 | |
| DSVASPLRESALMDI | 826 | Q6ZSZ6 | |
| MALEDRPSSLLVDQG | 1921 | O75962 | |
| EGQLNESMFLLSSRP | 351 | Q96C45 | |
| LSGDDDTDQNMRAPL | 16 | Q14789 | |
| MVLSQEEPDSARGTS | 1 | Q8TF71 | |
| TPDMLADGTRLQLAG | 801 | Q8N9H8 | |
| DEESRFPQGTDLTML | 511 | Q6PIF6 | |
| TMRLEQRDSLGESPV | 1936 | B2RTY4 | |
| GTLDLSMNKQRPRDS | 771 | Q9UL68 |